Home › NDC Lookup › RxCUI directory › RxCUI 1000479

{1 (bisacodyl 5 MG Delayed Release Oral Tablet) / 1 (2000 ML) (polyethylene glycol 3350 21... — RxCUI 1000479

RxNorm drug concept · Generic pack
RxCUI 1000479 Generic pack · GPCK ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1000479
Official name{1 (bisacodyl 5 MG Delayed Release Oral Tablet) / 1 (2000 ML) (polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asPEG-3350 210 GM / potassium chloride 0.740 GM / sodium bicarbonate 2.86 GM / sodium chloride 5.6 GM Powder for 2 L Oral Solution / 1 x bisacodyl 5 MG Delayed Release Oral Tablet; 1 (PEG-3350 210 GM / potassium chloride 0.74 GM / sodium bicarbonate 2.86 GM / sodium chloride 5.6 GM Powder for Oral Solution) / 1 (bisacodyl 5 MG Delayed Release Oral Tablet) Pack
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bisacodyl: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It relieves occasional constipation and irregularity. The Fleet enema is also used for fecal impaction and to clear residue after a barium test. It is meant for short-term use.
  • It depends on the form. Tablets usually work in 6 to 12 hours. Suppositories usually work in 15 minutes to 1 hour. The Fleet enema usually works in 5 to 20 minutes.
  • Not right away. Wait at least 1 hour after an antacid or milk before taking tablets. Swallow tablets whole with water and do not chew or crush them.
  • Can I take the tablets with an antacid or milk?
📖 Read our full Bisacodyl guide →

🕸️ Concept Web — How {1 (bisacodyl 5 MG Delayed Release Oral Tablet)... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {1 (bisacodyl 5 MG Delayed Release Oral Tablet) / 1 (2000 ML) (polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution) } Pack RxCUI 1000479

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Bisacodyl 1596
    • Polyethylene glycol 3350 221147
    • Potassium chloride 8591
    • Sodium bicarbonate 36676
    • Sodium chloride 9863
    • Polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride 815308
  2. Brand names 10

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Alophen Reformulated Jan 2008 750168
    • Bisac-Evac 215693
    • Correct (New Formula) 216229
    • Correctol laxative Reformulated Feb 2008 754460
    • Dulcolax 151672
    • Evac-U-Gen Reformulated Jan 2008 751981
    • Ex-lax Ultra 405055
    • Feen-A-Mint Reformulated Jan 2008 751985
    • +2 more in this family
  3. Dose forms 40

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bisacodyl Delayed Release Oral Tablet 371084
    • Polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride Powder for Oral Solution 1718982
    • Bisacodyl Oral Product 1154694
    • Bisacodyl Pill 1154695
    • Polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride Oral Powder Product 1718981
    • Polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride Oral Product 1162920
    • Bisacodyl Delayed Release Oral Tablet [Alophen Reformulated Jan 2008] 750170
    • Bisacodyl Delayed Release Oral Tablet [Bisac-Evac] 369810
    • +32 more in this family
  4. Clinical & branded drugs 27

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 31 of 84 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1000479 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43386-0071-83 1 KIT in 1 KIT (43386-071-83) * 1 TABLET, DELAYED RELEASE... GaviLyte-H and Bisacodyl Lupin Pharmaceuticals, Inc. 2015-04-21
Observed labelers: Lupin Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.